SEC Form 4 · accession 0000911916-18-000112
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tony W. Collins
Officer — VP, Controller and CAO
Period of report
Apr 30, 2018
Accepted (ET)
May 1, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 30, 2018 | M | 1,213 | $94.34 | A | 1,668 | D | |
| Common StockF2 | Apr 30, 2018 | S | 1,213 | $116.7653 | D | 455 | D | |
| Common Stock | Apr 30, 2018 | S | 117 | $116.32 | D | 338 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $94.34 | Apr 30, 2018 | M | 1,213 | D | — | Mar 17, 2024 | Common Stock | 1,213 | 0 | D |
Explanation of responses
- F1Includes 101 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between July 31, 2017 and January 30, 2018.
- F2Represents the sale of 1,213 shares in multiple transactions ranging in price from $116.22 to $117.04 per share, resulting in a weighted average sale price of $116.7653. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F31,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 options vested on March 17, 2018.